First-line immunotherapy combination treatments for metastatic kidney cancer
A meta-analysis of four major clinical trials of immunotherapy combinations [...]
Nivolumab for the treatment of metastatic non-clear cell renal cell carcinoma
Nivolumab alone and in combination with ipilimumab is used for [...]
COVID-19: Doctors given new guidelines for treating patients in critical care
Amid concerns that the NHS will be overwhelmed by the [...]
COVID-19 and cancer care at St Barts Hospital, London
Professor Thomas Powles, director of the cancer centre at Barts [...]
Activity Guide from the Patient Empowerment Network
We hope that you and your families are well and [...]
Coronavirus COVID-19 and cancer patients
A recent study from China looked at 1590 people infected [...]
Axitinib first-line treatment of papillary renal cell carcinoma
The majority of renal cell carcinomas (RCCs) are a subtype [...]
Advice on coronavirus from One Cancer Voice
Please find below advice on coronavirus for people with cancer [...]
Individualised axitinib dosing for patients with metastatic kidney cancer
In the following video interview with Practice Update, Dr Nancy [...]
Safety and efficacy of restarting immune checkpoint inhibitors after immune-related adverse events
Immune checkpoint inhibitors can cause a number of immune-related adverse [...]
